Cell-Based Gene Transfer to the Pulmonary Vasculature: Endothelial Nitric Oxide Synthase Overexpression Inhibits Monocrotaline-Induced Pulmonary Hypertension

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 5, 1999, Pages 567-575

  Campbell, Andrew I M ^a   Kuliszewski, Michael A ^a   Stewart, Duncan J ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MARTES PENNANTI;

(((4 CHLOROMETHYL)BENZOYL)AMINO) TETRAMETHYLRHODAMINE; (((4-CHLOROMETHYL)BENZOYL)AMINO)-TETRAMETHYLRHODAMINE; BETA GALACTOSIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCENT DYE; MONOCROTALINE; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, RAT; RHODAMINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE; CELL CULTURE; CELL TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; ENZYMOLOGY; FISCHER 344 RAT; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; HEART RIGHT VENTRICLE FUNCTION; LUNG; METABOLISM; PULMONARY HYPERTENSION; RAT; TIME; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; BETA-GALACTOSIDASE; BLOOD PRESSURE; CELL TRANSPLANTATION; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT DYES; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HYPERTENSION, PULMONARY; LUNG; MONOCROTALINE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED F344; RHODAMINES; TIME FACTORS; TRANSFECTION; VENTRICULAR FUNCTION, RIGHT;

EID: 0033219861     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.5.3640     Document Type: Article

References (41)

1. De Young, M. B., and D. A. Dichek. 1998. Gene therapy for restenosis: are we ready? Circ. Res. 82:306-313.
2. Rekhter, M. D., R. D. Simari, C. W. Work, G. J. Nabel, F. G. Nabel, and D. Gordon. 1998. Gene transfer into normal and atherosclerotic human blood vessels. Circ. Res. 82:1243-1252.
3. Dichek, D. A., J. Anderson, A. B. Kelly, S. R. Hanson, and L. A. Harker. 1996. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 93:301-309.
4. Rade, J. J., A. H. Schulick, R. Virmani, and D. A. Dichek. 1996. Local adenoviral-mediated expression of recombinant hirudin reduces necointima formation after arterial injury. Nat. Med. 2:293-298.
5. Stephan, D., H. San, Z. Y. Yang, D. Gordon, S. Goelz, G. J. Nabel, and E. G. Nabel. 1997. Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol Med. 3:593-599.
6. Newman, K. D., P. F. Dunn, J. W. Owens, A. H. Schulick, R. Virmani, G. Sukhova, P. Libby, and D. A, Dichek. 1995. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin. Invest. 96:2955-2965.
7. Schulick, A. H., K, D, Newman, R. Virmani, and D. A, Dichek. 1995. In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity, Circulation 91:2407-2414.
8. Piedimonte, G., R, J, Pickles, J. R. Lehmann, D. McCarty, D. L. Costa, and R. C. Boucher. 1997. Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation. Am. J. Respir. Cell Mol. Biol. 16:250-258.
9. Crystal, R, G., A. Mastrangeli, A. Sanders, J. Cooke, T. King, F, Gilbert, C. Henschke, W. Pascal, J. Herena, and B. G. Harvey. 1995. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airwavs of individuals with cystic fibrosis. Hum. Gene Ther. 6:667-703.
10. Cornetta, K., R. A. Morgan, and W. F. Anderson. 1991, Safety issues related to retroviral-mediated gene transfer in humans. Hum. Gene Ther. 2:5-14.
11. Weiss, R. A. 1992, Retroviruses and human cancer. Semin. Cancer Biol. 3:321-328.
12. Weiss, R. A. 1987, Retroviruses and human disease. J. Clin. Pathol, 40: 1064-1069.
13. Grossman, M., D. J. Rader, D. W. Mullet, D. M. Kolansky, K. Kozarsky, B. J. Clark, III, E, A, Stein, P, J. Lupien, H. B, Brewer, Jr., and S, E. Raper. 1995. A pilot study of ex vivo gene therapy for homozygous familial hyper-cholesterolaemia. Nat. Med. 1:1148-1154.
14. Raper, S, E., M. Grossman, D. J. Rader, J. G. Thoene, B, J. Clark, III, D. M, Kolansky, D. W. Muller, and J. M. Wilson. 1996, Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypereholesterolemia. Ann. Surg. 223:116-126.
15. Gaine, S. P., and I. J, Rubin. 1998. Primary pulmonary hypertension. Lancet 352:719-725.
16. Fishman, A. P. 1998. Etiology and pathogenesis of primary pulmonary hypertension: a perspective, Chest 114:242S-247S.
17. Reitz, B. A., J. L. Wallwork, S. A. Hunt, J. L. Pennock, M. F. Billingham, P. F. Oyer, F. B. Stinson, and N. E. Shumway. 1982, Heat-lung transplantation: successful therapy for patients with pulmonary vascular disease. N. Engl. J. Med. 306:557-564.
18. Gaine, S. P., and L. J, Rubin. 1998. Medical and surgical treatment options for pulmonary hypertension. Am. J. Med. Sci. 315:179-184.
19. Weir, E. K., and B. Schremmer. 1998. Vasodilators in the treatment of primary pulmonary hypertension [editorial], Eur. Respir. J. 12:263-264.
20. Higenbottam, T. W., A. Y. Butt, A, T. Dinh-Xaun, M, Takao, G. Cremona, and S. Akamine. 1998. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprosl. Heart 79:175-179.
21. Okano, Y., S. Senju, Y. Tsutsui, S. Kyotani, M. Ishibashi, M. Yoshida, and T. Kunieda, 1997. Long-term continuous intravenous infusion of prostacyclin for severe primary pulmonary hypertension. Intern. Med, 36:794-798.
22. Barst, R, J., L. J. Rubin, W. A. Long, M. D, McGoon, S, Rich, D, B, Badeseh, B. M, Groves, V, E Tapson, R. C. Bourge, and B. H. Brundage. 1996. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group. N. Engl. J. Med. 334:296-302.
23. Schmiedt, M. I., U. R. Shettigar, M. Siddique, G. Barbier, M. Bialow, and S. Carranza. 1998. Unpredictable response to vasodilator therapy in primary-pulmonary hypertension. Int. J. Clin. Pharmacol. Ther. 36:435-440.
24. Castro, P, F., R, C, Bourge, D, C, McGiffin, R. L, Benza, P. Fan, N. B, Pinkard, and M. D. McGoon. 1998. Intrapulmonary shunting in primary pulmonary hypertension: an observation in two patients treated with epoprostenol sodium. Chest 114:334-336.
25. Shaul, P. W., L. B. Wells, and K. M. Horning. 1993. Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms, J. Cardiovasc. Pharmacol. 22:819-827.
26. North, A. J., F. R. Moya, M. R, Mysore, V. L. Thomas, L. B. Wells, L. C. Wu, and P. W. Shaul. 1995. Pulmonary endothelial nitric oxide synthase gene expression is decreased in a rat model of congenital diaphragmatic hernia. Am. J. Respir. Cell Mol. Biol. 13:676-682.
27. Xue, C., and R. A, Johns. 1995. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333: 1642.
28. Giaid, A., and D, Saleh. 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333:214-221.
29. Tjen-A-Laoi, S., R. Ekman, J. Osborn, and J. Keith. 1996. Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study, Am. J. Physiol. 271:H2246-H2253.
30. Dinh-Xuan, A. T., G. Cremona, and T. W. Higenbottam. 1994. Endothelial dysfunction and remodelling of the pulmonary circulation in chronic hypoxic pulmonary hypertension. A C P J. Club 5:93 99.
31. Giaid, A., M. Yanagisawa, D. Langleben, R. P. Michel, R. Levy. H. Shennih, S, Kimura, T. Masaki, W. P. Duguid, and D, J. Stevvart, 1993. Expression of endothelin-1 in the lungs of patients with pulmonary hypertention. N. Engl. J. Med. 328:1732-1739.
32. Yoshibayashi, M., K, Nishioka, K. Nakao, Y. Saito, M, Matsumura, T, Ueda, S. Temma, G. Shirakami, H. Imura, and H. Mikawa. 1991. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects: evidence for increased production of endothelin in pulmonary circulation. Circulation 84:2280-2285.
33. Eddahibi, S., B, Raffestin, P. Braquet, P. E., Chabrier, and S. Adnol. 1991. Pulmonary vascular reactivity to endothelin-1 in normal and chronically pulmonary hypertensive rats. J. Cardiovasc. Pharmacol. 17(Suppl. 7):S358-S361.
34. Schachtner, S. K., J. J. Rome, R. F. Hoyt, Jr., K. D. Newman, R. Virmani, and D. A. Dichek. 1995. In vivo adenovirus-mediated gene transfer via the pulmonary artery of rats. Circ Res. 76:701-709.
35. Rodman, D. M., H. San, R. Simari, D. Stephan, F. Tanner, Z. Yang, G. J, Nabel, and E. G. Nabel. 1997. In vivo gene delivery to the pulmonary circulation in rats: transgene distribution and vascular Inflammatory response. Am. J. Respir. Cell Mol. Biol. 16:640-649.
36. Aharoni, D., I. Meiri, R. Atzmon, I. Vlodavsky, and A. Amsterdam. 1997. Differential effect of components of the extracellular matrix on differentiation and apoptosis. Curr, Biol. 7:43-51.
37. Pullan, S., J, Wilson, A, Metcalfe, G. M. Edwards, N. Goberdhan, J. Tilly, J. A. Hickman, C. Dive, and C, H. Streuli. 1996. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell. Sci. 109:631-642.
38. Liptay, S., R. M. Schmid, E. G. Nabel, and G. J. Nabel. 1994. Transcriptional regulation of NF-kappa B2: evidence for kappa R-mediated positive and negative autoregulalion. Mol. Cell Biol. 14:7695-7703.
39. Ooboshi, H., T. D. Rios, Y. Chu, S. D. Christenson, F. M. Faraci, B. L. Davidson, and D. D. Heistad, 1997. Augmented adenovirus-mediated gene transfer to atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17:1786-1792.
40. Nabel, E, G., Z, Yang, D, Muller, A, F. Chang, X. Gao, L. Huang, K. J. Cho, and G. J. Nabel. 1994. Safely and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. Hum. Gene Ther. 5:1089-1094.
41. Janssens, S. P., K. D. Bloeh, Z. X. Nong, R. D. Gerard, P. Zoldhelyi, and D. Collen. 1996. Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J. Clin. Clin. 98:317-324.